Stock screenerAll disclosures →
EDGAR →
DERM
Conviction 38HealthcareScan · Thu, Jun 25, 2026DERM$6.24-8.91%
ResistanceSupportVol 14Vol MA14 396.42K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price6.24
Change-8.91%
Gap+1.46%
Rel volume7.85×
Avg volume335.03K
Avg $ vol2.1M
SMA 206.23
SMA 505.76
SMA 2007.12
Price vs 50+8.33%
Price vs 200-12.37%
MA stackmixed
50/200 cross—
Supertrendup · 5.74
RSI (14)52
MACD hist0.02
MACD crossbull · 2d
Stoch %K / %D30 / 64
ADX (14)21
+DI / −DI24 / 19
RSI divergence—
MACD divergence—
ATR %+6.57%
ADR %6.02%
52w high9.26
52w low4.39
From 52w high-32.61%
Above 52w low+42.14%
New 52w highNo
SqueezeOn · 10d
Bollinger width14.58%
%B0.51
Donchian pos31.88%
Donchian high7.18
Donchian low5.80
AVWAP (52w high)6.19
vs AVWAP high+0.79%
AVWAP (52w low)5.76
vs AVWAP low+8.28%
OBV trendFlat
Chaikin MF (20)-0.32
Today vs 20d7.85×
Avg vol (14d)396.42K
Avg vol (20d)335.03K
Avg $ vol (20d)2.1M
Market cap72.11M
RS 3m (vs SPY)-13.13%
RS 6m (vs SPY)-20.70%
RS line new highNo
Trend template2/8
Technical rank39.6
1 week+5.41%
1 month+1.96%
3 months-8.64%
6 months-22.10%
1 year-10.22%
YTD-16.24%
P/E-6.31
P/B2.34
P/S1.18
P/FCF-2.63
EPS-0.4700
Div yield—
ROE-37.08%
ROA-12.49%
Debt/Eq0.82
Current1.72
EV/EBITDA-8.60
Gross margin—
Net margin-18.67%
Rev growth11.07%
EPS growth22.09%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value70.27M
Revenue15.92M
Net income-2.23M
Gross profit—
Free cash flow-27.44M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out21.53M
Employees58
ListedFri, Nov 12, 2021
Free float13.4M
Float %49.2%
Short interest3.51M
Days to cover14.2d
Short volume36.7%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction38 / 100
Pattern quality—
Tech rank39.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance6.59
Support5.30
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in DERM
No recent disclosed trades by Congress in DERM. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in DERM · 6 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Maraoui Claude President & CEO · Common Stock, $0.0001 par value · 2026-04-22 | Grant | 49.28K | $0 | 2026-04-22 | 2026-04-24 |
Alloush Ramsey Chief Operating Officer · Stock Option (Right to Buy) · 2026-04-22 | Grant | 62.8K | $0 | 2026-04-22 | 2026-04-24 |
Benesch Joseph CFO · Stock Option (Right to Buy) · 2026-04-22 | Grant | 41.86K | $0 | 2026-04-22 | 2026-04-24 |
Maraoui Claude President & CEO · Stock Option (Right to Buy) · 2026-04-22 | Grant | 82.92K | $0 | 2026-04-22 | 2026-04-24 |
Alloush Ramsey Chief Operating Officer · Common Stock, $0.0001 par value · 2026-04-22 | Grant | 46.86K | $0 | 2026-04-22 | 2026-04-24 |
Benesch Joseph CFO · Common Stock, $0.0001 par value · 2026-04-22 | Grant | 28.91K | $0 | 2026-04-22 | 2026-04-24 |
SEC filings
EDGAR filings in DERM
No recent SEC filings on file for DERM.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.